Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study
Richard B. Lipton(Albert Einstein College of Medicine), Eric Pearlman(University of California, San Francisco), John Rowland(Icahn School of Medicine at Mount Sinai), Michael L. Reed, Dena H. Jaffe, Douglas E. Faries(Eli Lilly (United States)), Andre B. Araujo(Moderna Therapeutics (United States)), Sait Ashina(University of Copenhagen), M. Janelle Cambron‐Mellott(Kantar Health (United States)), Robert A. Nicholson(Eli Lilly (United States)), Robert E. Shapiro(University of Vermont), Dawn C. Buse(Albert Einstein College of Medicine)
Cited by 150
Related Papers
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
|The Journal of Clinical Endocrinology & Metabolism|2002|1.8k
Prevalence and Incidence of Androgen Deficiency in Middle-Aged and Older Men: Estimates from the Massachusetts Male Aging Study
|The Journal of Clinical Endocrinology & Metabolism|2004|588
Targeted Disruption of the Chemokine Eotaxin Partially Reduces Antigen-induced Tissue Eosinophilia
|The Journal of Experimental Medicine|1997|532
Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies
|Journal of Alzheimer s Disease|2015|469
N-GSDMD trafficking to neutrophil organelles facilitates IL-1β release independently of plasma membrane pores and pyroptosis
|Nature Communications|2020|453